These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 19442950)

  • 1. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.
    Higo T; Ueda Y; Oyabu J; Okada K; Nishio M; Hirata A; Kashiwase K; Ogasawara N; Hirotani S; Kodama K
    JACC Cardiovasc Imaging; 2009 May; 2(5):616-24. PubMed ID: 19442950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.
    Oyabu J; Ueda Y; Ogasawara N; Okada K; Hirayama A; Kodama K
    Am Heart J; 2006 Dec; 152(6):1168-74. PubMed ID: 17161071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima.
    Yokoyama S; Takano M; Yamamoto M; Inami S; Sakai S; Okamatsu K; Okuni S; Seimiya K; Murakami D; Ohba T; Uemura R; Seino Y; Hata N; Mizuno K
    Circ Cardiovasc Interv; 2009 Jun; 2(3):205-12. PubMed ID: 20031717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioscopy study from a large patient population comparing sirolimus-eluting stent with biodegradable versus durable polymer.
    Chen SL; Xu T; Zhang JJ; Ye F; Hu ZY; Tian NL; Zhang YJ; Kotani J; Zhang JX
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):420-8. PubMed ID: 21953920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
    Sera F; Awata M; Uematsu M; Kotani J; Nanto S; Nagata S
    JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of a newly developed yellow neointima at stent implanted site 1 year after sirolimus-eluting stent placement: angioscopic findings.
    Kawakami H; Matsuoka H; Oshita A; Kono T; Shigemi S
    J Cardiol; 2009 Aug; 54(1):153-7. PubMed ID: 19632537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Satisfactory arterial repair 1 year after ultrathin strut biodegradable polymer sirolimus-eluting stent implantation: an angioscopic observation.
    Ishihara T; Awata M; Iida O; Fujita M; Masuda M; Okamoto S; Nanto K; Kanda T; Tsujimura T; Uematsu M; Mano T
    Cardiovasc Interv Ther; 2019 Jan; 34(1):34-39. PubMed ID: 29335827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.
    Yamamoto M; Takano M; Murakami D; Inami T; Kobayashi N; Inami S; Okamatsu K; Ohba T; Ibuki C; Hata N; Seino Y; Jang IK; Mizuno K
    Am Heart J; 2011 Jun; 161(6):1200-6. PubMed ID: 21641369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of angioscopic findings among second-generation drug-eluting stents.
    Nishimoto Y; Ueda Y; Sugihara R; Murakami A; Ueno K; Takeda Y; Hirata A; Kashiwase K; Higuchi Y; Yasumura Y
    J Cardiol; 2017 Sep; 70(3):297-302. PubMed ID: 28034576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation.
    Kim JS; Kim JS; Kim TH; Fan C; Lee JM; Kim W; Ko YG; Choi D; Hong MK; Jang Y
    Circ J; 2010 Feb; 74(2):320-6. PubMed ID: 20019414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy).
    Ueda Y; Matsuo K; Nishimoto Y; Sugihara R; Hirata A; Nemoto T; Okada M; Murakami A; Kashiwase K; Kodama K
    JACC Cardiovasc Interv; 2015 May; 8(6):814-821. PubMed ID: 25999104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of neointimal coverage of sirolimus-eluting stents--evaluation with optical coherence tomography.
    Ishigami K; Uemura S; Morikawa Y; Soeda T; Okayama S; Nishida T; Takemoto Y; Onoue K; Somekawa S; Takeda Y; Kawata H; Horii M; Saito Y
    Circ J; 2009 Dec; 73(12):2300-7. PubMed ID: 19789417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation.
    Ishihara T; Sotomi Y; Tsujimura T; Iida O; Kobayashi T; Hamanaka Y; Omatsu T; Sakata Y; Higuchi Y; Mano T
    Cardiovasc Diabetol; 2020 Dec; 19(1):203. PubMed ID: 33267863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.